Europe's aversion to GM crops has killed investors' appetites for agricultural research. Even in the UK, historically a world leader in this field, it is almost impossible to commercialise agricultural biotechnology of any kind.
As the countries of the European Union struggle to meet their targets for R&D growth, they are looking at new tax breaks for entrepreneurs. Good news, or too little too late?